Companies / Santa Cruz Biotechnology / CD7 (Huly-m2) PE
Santa Cruz Biotechnology

CD7 (Huly-m2) PE | Santa Cruz Biotechnology

mouse monoclonal IgG2a; CD7 (also designated T cell leukemia antigen) is a type I transmembrane glycoprotein that is expressed on pluripotential hemapoietic cells, most human thymocytes and some peripheral blood T cells. CD7 is a marker for pluripotential stem cell leukemias and T cell acute lymphocytic leukemia. A role for CD7 in the activation of T cells with g/d receptors has been suggested. CD8 T cells from patients infected with HIV-1 displayed profound down-modulation of CD7 expression as compared with healthy subjects. CD7 is among the pan-T-cell antigens down-regulated in acute infectious mononucleosis.

Reviews


No reviews yet